Type 2 diabetes is not associated with excess risk of periprosthetic joint infection in obese patients undergoing total hip arthroplasty

Key Points

• Type 2 diabetes does not correlate with higher periprosthetic joint infection risk in obese individuals.
• The analysis reviewed infection rates in patients undergoing total hip arthroplasty, focusing on obesity and diabetes status.
• Findings suggest that obesity and diabetes should be assessed separately concerning surgical risk.
• The results imply that diabetes may not necessarily complicate total hip arthroplasty outcomes for obese patients.